Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
HitGen has formed a drug discovery research collaboration with Boehringer Ingelheim to identify novel small-molecule leads.
Quotient Clinical has rebranded as Quotient Sciences, and right after that, made its third purchase this year.
Aquila BioMedical signed an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.
Bioclinica is looking to broaden its reach with the purchase of MDDX Research & Informatics.
Imricor Medical Systems and Mirtle Medical are combining their offerings to create an alternative to x-ray guided ablation.
Major CRO player PPD has won a lucrative seven-year government contract in infectious disease.
Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.
Medical devices-focused CRO Factory has expanded in North America with the acquisition of Milestone.
Germany’s Evotec has penned another deal amid a stream of R&D pacts over the past year, this time with PARP player Tesaro.
Major CRO Parexel has teamed up with tech giant Microsoft to create a new cloud tech alliance, all aimed at speeding up drug research.